Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
KDM6B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
MITF - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SIGLEC11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PUS3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GJC2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
VPS54 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PCDH11X - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100505984 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DNAAF5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EZR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OBP2A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
SPTB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LCK - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NPAS3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC00884 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DOCK4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CYP2D6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ANPEP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on